heartbase Modules:

Certified in all modules and adhere to strict registry rules, specifications & field definitions.  Version updates, report and software enhancements included in purchase and renewal price.

Enables timely compliance and provides valuable hospital tools to know & use its “owned” date throughout pre & post harvest submission periods.

heartbase module reports are used to analyze procedural complications, benchmark against national rolling averages while supporting quality improvement initiatives.

Provides pre-harvest tools to determine missing registry data elements.



Please click the product names below for full details
NCDR-ACC: CATHPCI Registry
The heartbase™ ACC-NCDR Cath/PCI Registry is designed for collecting, reporting and benchmarking Cardiac Catheterization(CATH) and Percutaneous Coronary Intervention(PCI) procedures including history/risk factors, cardiac status, treated lesions, intracoronary device utilization and adverse event rates rate  

NCDR-ACC: CARE Registry
Supporting multiple disciplines of medicine –cardiology, neurology, radiology, vascular surgery, neurosurgery, and interventional neuroradiology, the Carotid Artery Revascularization and Endarterectomy (CARE) Registry was designed in partnership with the Society for Cardiovascular Angiography and Interventions, the Society of Interventional Radiology and the American Academy of Neurology.  Fulfilling CMS data collection requirements for carotid implantations and targeted for patients receiving carotid artery stents(CAS) and undergoing endarterectomy(CEA) procedures, the registry captures key fields to benchmark patient outcomes, use of balloons, stents, and embolic protection devices, volumes, utilization, medications,  neurological status and adverse event rates. 

NCDR-ACC: ICD Registry
The Implantable Cardioverter Defibrillator (ICD) registry was designed in partnership with the Heart Rhythm Society in 2005 and includes required data fields for Centers for Medicare and Medicaid (CMS) data collection.  The heartbase module meets the CMS requirements for ICD implantation and incorporates required ACC and American Hospital Association (AHA) electrophysiology fields.  The fields include patient characteristics, device types, extent of disease progression,  patient outcomes and has been expanded to capture atrial, ventricular, defibrillator and left-heart lead data at time of implant, revision, replacement, or surgical abandonment, pediatric ICD implantation data and ICD/CRT-D generators for primary and secondary prevention. 
NCDR-ACC: ACTION Registry
For measuring data on high-risk STEMI/NSTEMI myocardial infarction patients, the Acute Coronary Treatment & Interventional Outcomes Network or NCDR®-ACTION Registry was established in 2007 through the collaboration of the National Registry of Myocardial Infarction (NRMI) and American Hospital Association (AHA) Crusade Registries.  In 2008, NCDR®-ACTION collaborated with American Hospital Association - Get With The Guidelines to provide a nationally risk-adjusted outcomes-based quality improvement program to measure clinical outcomes and drug safety, provide treatment protocols and promote quality improvement for high-risk acute coronary syndrome (ACS) patients with STEMI and NSTEMI.  Features include:  AMI performance measures, tracking medication dosing patterns, lipid metrics, discharge medications and risk-factor interventions.

NCDR-ACC: IMPACT
(IMproving Pediatric and Adult Congenital Treatment) to assess the prevalence, demographics, management and outcomes of pediatric and adult patients with congenital heart disease who are undergoing diagnostic catheterizations and catheter-based interventions.  The heartbase™ IMPACT module is in development and available TBD upon client request. 
STS: Adult Cardiac Surgery
In 1990, the STS database initiated its program for quality improvement, patient safety and clinical research by collecting data on coronary bypass, valve and valve/coronary procedures.  By utilizing the Adult Cardiac Surgery risk stratification models for operative mortality and measures for cost effectiveness for operative morbidity and length of stay, hospitals are able to establish and monitor quality initiative programs, seek accreditation, and benchmark outcomes.  V2.73 contains over 700 data elements to more comprehensively capture preoperative factors to assess surgical risk.  Expanded sections for coronary data fields include information on conduits, target vessels and techniques in bypass surgery, as well as the additional valve assessment and repair data fields and aortic procedures and surgery for adults with congenital heart disease.    STS risk models are embedded in the STS modules and allows a user to calculate a patient’s risk of mortality and other morbidities, such as long length of stay and renal failure.  Incorporating the specified CMS cardiothoracic surgery reporting measures, enables participation in the Physician Quality Reporting System(PQRS).
STS: Congenital Heart Surgery
The heartbase Congenital Heart Surgery module incorporates all parameters from the STS Heart Surgery Database.  For V3.0, The Congenital Heart Surgery Database Task Force, in cooperation with the congenital heart surgery community, further redefined and standardized the STS nomenclature for congenital heart surgery.  Participation fulfills requirements set forth by third-party entities, major corporate purchasers of health care, health care systems, and government agencies who require outcome monitoring and participation in quality improvement programs.  V.3.0 includes a new anesthesia section, the addition of approximately 50 fields that are collected for adult patients only and Aristotle™ Complexity Scores.    
STS: General Thoracic Surgery
Participation in the Society of Thoracic Surgeons (STS) national registry provides advantages such as the ability to benchmark data and access comparative quality of care information.  The Thoracic module incorporates all parameters from the STS Thoracic Surgery Database.  The module incorporates information from demographic, hospitalization, clinical presentation, and examines procedure and complications in detail.  In 2012 the American Board of Thoracic Surgery will require all diplomats to participate in a clinical outcomes database.  They need to be able to compare data and outcomes in order to improve their practice.  V2.2x is currently in development and will be released in January 2012. 
The Joint Commission Core Measure: Acute Myocardial Infarction (AMI)
An initial measure, AMI incorporates performance measures developed by the American Heart Association (AHA) and American College of Cardiology (ACC).  The AMI Core Measure dataset provides users with a comprehensive data set that compliments the ACC or STS modules for patients experiencing myocardial infarction.  The Joint Commission will only require data collection of AMI-7a. 
The Joint Commission Core Measure: Children's Asthma Care (CAC)

Implemented in 2007, the CAC Core Measure set includes parameters to assess the processes of care for pediatric patients with asthma.  The measures specifically address:  the use of relievers for inpatient asthma, the use of systemic corticosteroids for inpatient asthma, and home management plan of care given to patient/caregiver. The Joint Commission worked in collaboration with national children’s health care organizations, particularly, National Association of Children’s Hospitals and Related Institutions (NACHRI), Child Health Corporation of America (CHCA), and Medical Management Planning, Inc. (MMP).  Effective January 1, 2015, The Joint Commission will retire the following measures:  CAC-1 and CAC-2.   The Joint Commission will be providing accredited hospitals greater flexibility in meeting ORYX® performance measure reporting requirements beginning with measure set selections for calendar year 2015.


The Joint Commission Core Measure: Pneumonia (PN)

An initial measure, The Joint Commission collaborates with the Centers for Medicare and Medicaid Services (CMS) as well as the Infectious Disease Society of America (IDSA), the American Thoracic Society (ATS), the American Society of Emergency Room Physicians (AQSEP), and the Centers for Disease Control and Prevention (CDC) with respect to the performance measures for patients with pneumonia. There are currently 4 measures associated with the PN measure set.  


The Joint Commission Core Measure: Heart Failure (HF)
 The Joint Commission will no longer require data collection for this measure set. The Joint Commission will be providing accredited hospitals greater flexibility in meeting ORYX® performance measure reporting requirements beginning with measure set selections for calendar year 2015. 
The Joint Commission Core Measure: Hospital Out-Patient Department (OP)
Introduced in 2007 and maintained by CMS, the hospital outpatient measures listed in the Centers for Medicare and Medicaid Services (CMS) Outpatient Prospective Payment System (OPPS) Calendar Year 2008 Proposed Rule meet the requirements set forth in the Tax Relief and Health Care Act of 2006 (Section 109).In November 2007, The Joint Commission announced the addition of a set of seven hospital outpatient measures to its current complement of core measure sets used to satisfy ORYX performance measurement requirements. The hospital outpatient measures listed in the Centers for Medicare and Medicaid Services (CMS) Outpatient Prospective Payment System (OPPS) Calendar Year 2008 Proposed Rule meet the requirements set forth in the Tax Relief and Health Care Act of 2006 (Section 109).

The hospital outpatient measure set provides accredited hospitals with a broader array of measure sets from which to meet ORYX requirements, and supports the ability of hospitals to meet multiple measurement requirements with a single data collection effort.  Joint Commission accredited hospitals are required to collect and submit data to The Joint Commission for a minimum of six core measure sets.  The existing technical infrastructure, which specifically includes contracted performance measurement systems, continues to serve as the principal vehicle for hospital data collection and transmission.


The Joint Commission Core Measure: Perinatal Care (PC)

In late 2007, The Joint Commission’s Board of Commissioners recommended retiring and replacing the Pregnancy and Related Conditions (PR) measure set with an expanded set of evidenced-based measures. A technical advisory panel (TAP) comprising experts in the perinatal care field was convened in February 2009 to select the replacement set of measures from among those endorsed for national use by the National Quality Forum.  This expanded measure set, now referred to as the Perinatal Care (PC) measures is comprised of 5 measures. The measure maintenance process is guided by expertise and advice provided by the Perinatal Care Measure Maintenance Technical Advisory Panel.

Hospitals began collecting data for the PC measures beginning with April 1, 2010 discharges. All of the PC measures were re-endorsed by the National Quality Forum (NQF) on March 30, 2012.


The Joint Commission Core Measure: Surgical Care Improvement Program (SCIP)

The Surgical Infection Prevention (SIP) measures were added as a core measure set in the fall of 2003.  Hospitals began collecting core measure data for SIP with patient discharges beginning July 1, 2004.  The SIP set subsequently transitioned to the Surgical Care Improvement Project (SCIP) measures effective July 1, 2006.

The Surgical Care Improvement Project (SCIP) is a national quality partnership of organizations interested in improving surgical care by significantly reducing surgical complications.  SCIP Partners include the Steering Committee of 10 national organizations who have pledged their commitment and full support for SCIP.

In addition, the SCIP target areas are advised by a technical expert panel (TEP). This group meets on a quarterly basis and provides technical expertise and resources to ensure the SCIP measures are fully supported by evidence-based research.   

Finally, The Joint Commission continues to align with Centers for Medicare and Medicaid Services (CMS) with respect to the performance measures for patients undergoing surgery..


The Joint Commission Core Measure Stroke (STK)

The stroke (STK) measures were developed in collaboration with the American Heart Association (AHA)/American Stroke Association (ASA)/Brain Attack Coalition (BAC) for use by Disease-Specific Care (DSC)-certified primary stroke centers. In 2009, the STK eight-measure set was approved as a core measure set for use in the Joint Commission’s ORYX program, and may be selected by hospitals to meet their six core measure set accreditation requirement, dependent upon vendor support of this measure set.  The measure maintenance process is guided by expertise and advice provided by the Stroke Measure Maintenance Technical Advisory Panel.   STK measure specifications are aligned with the Centers for Medicare & Medicaid Services as well as harmonized with data elements contained in the AHA Get With The GuidelinesSM (GWTG)-Stroke patient management tool and the Centers for Disease Control and Prevention (CDC) Paul Coverdell National Acute Stroke Registry (PCNASR). Seven measures in the stroke set were re-endorsed by the National Quality Forum (NQF) on November 1, 2012; endorsement for the stroke education measure was removed. 


The Joint Commission Core Measure: Venous Thromboembolish (VTE)
The venous thromboembolism (VTE) measures were developed as a result of the ‘National Consensus Standards for the Prevention and Care of Deep Vein Thrombosis (DVT)’ project between The Joint Commission and the National Quality Forum (NQF) that formally began in January 2005.  The development process was guided by the expertise and advice provided by the NQF steering committee (SC) and the technical advisory panel (TAP).  The measures were tested through a multi-phased approach and the results were reviewed by the SC and TAP.
  
Six VTE measures were endorsed by the NQF in May, 2008 and aligned with the Centers for Medicare & Medicaid Services.  The VTE measure set was approved as a core measure set for use in the Joint Commission’s ORYX program, and available for selection by hospitals to meet their four core measure set accreditation requirement effective May 1, 2009, dependent upon vendor support of this measure set.
The Joint Commission Core Measure: Immunization (IMM)

The Immunization measures were developed as a result of recommendations in 2006 from a National Quality Forum (NQF) Harmonization Workgroup that influenza and pneumococcal vaccination measures should apply to all patients regardless of diagnosis.  In 2007 NQF and CMS sponsored the CMS Adult Immunization Task Force with a goal of developing influenza and pneumococcal measures that could cross care settings and would be applicable to all patients.  Collaborative work then began between CMS and The Joint Commission to develop 2 hospital measures that could eventually replace the two diagnosis specific pneumonia measures (PN 2 Pneumococcal Vaccination and PN 7 Influenza Vaccination) with immunization measures that would address all hospitalized inpatients. 

The result of this collaboration was the development of two measures, which will become effective for discharges on and after January 1, 2012:

  • IMM-1a  Pneumococcal Immunization (PPV23) – Overall rate
  • IMM-1b  Pneumococcal Immunization (PPV23) – Age 65 and Older
  • IMM-1c  Pneumococcal Immunization (PPV23) – High Risk Populations  (Age 6 through 64 years)
  • IMM-2    Influenza Immunization
  • Effective 1/1/2014, due to variances in guidelines and vaccine administration recommendations, IMM-1a, 1b, and 1c data collection was suspended for The Joint Commission and is voluntary for CMS.

 


The Joint Commission Core Measure: Emergency Department (ED)

The Emergency Department (ED) measure set was developed by the Centers for Medicare and Medicaid Services (CMS) and has been adopted by The Joint Commission’s ORYX program in order to maintain alignment with CMS reporting requirements.   The ED measure set became available for selection by hospitals to meet their six core measure set accreditation requirement effective January 1, 2012.

The ED measure set comprises two measures and addresses all hospitalized inpatients, irrespective of their diagnosis/clinical condition.


The Joint Commission Core Measure: Tobacco Treatment (TOB)

In late 2008, The Joint Commission received funding from the Partnership for Prevention and the Substance Abuse and Mental Health Services Administration (SAMHSA) of the Department of Health and Human Services, to develop, specify, and test standardized performance measures addressing tobacco and alcohol screening and cessation counseling. Working with a Technical Advisory Panel  8 performance measures (4 for Tobacco Treatment, and 4 for  Substance Use) were suggested that would address all hospitalized inpatients, irrespective of their diagnosis/clinical condition known as global (population) performance measures.  A 6 month pilot test was conducted in 2010.. Following the pilot test, the measures were separated into two distinct measure sets (Tobacco Treatment-TOB, and Substance Use – SUB).

The TOB measure set  comprising 4 measures was approved as a core measure set for use in the Joint Commission’s ORYX program, and became available for selection by hospitals to meet their  six core measure set accreditation requirement effective January 1, 2012. The measure maintenance process is guided by expertise and advice provided by the TOB Measure Maintenance Technical Advisory Panel.  Three measures in the TOB set were endorsed by the National Quality Forum (NQF) on February 18, 2014. The follow-up measure was not endorsed.


The Joint Commission Core Measure: Substance Use (SUB)

 In late 2008, The Joint Commission received funding from the Partnership for Prevention and the Substance Abuse and Mental Health Services Administration (SAMHSA) of the Department of Health and Human Services, to develop, specify, and test standardized performance measures addressing tobacco and alcohol screening and cessation counseling. Working with a Technical Advisory Panel  8 performance measures (4 for Tobacco Treatment, and 4 for  Substance Use) were suggested that would address all hospitalized inpatients, irrespective of their diagnosis/clinical condition known as global (population) performance measures.  A 6 month pilot test was conducted in 2010. . Following the pilot test, the measures were separated into two distinct measure sets (Tobacco Treatment-TOB, and Substance Use– SUB).

The SUB measure set containing 4 measures was approved as a core measure set for use in the Joint Commission’s ORYX program, and became available for selection by hospitals to meet their  six core measure set accreditation requirement effective January 1, 2012. The measure maintenance process is guided by expertise and advice provided by the SUB Measure Maintenance Technical Advisory Panel. Three measures in the SUB set were endorsed by the National Quality Forum (NQF) on February 18, 2014. The follow-up measure was not endorsed.


Get With The Guidelines: Stroke

The Get With The Guidelines®–Stroke (GWTG-Stroke) program is provided by the American Heart Association/American Stroke Association with the mission to help hospitals improve outcomes in stroke patients.  The module contains 275 fields which includes parent child relationships and encompasses the total stroke encounter.  Hospitals are able to track their program’s performance and pinpoint areas for improvement.  GWTG awards Silver, Gold, Silver Plus and Gold Plus designations to hospitals meeting their criteria and are honored at national recognition events during the International Stroke Conference and listed by name in advertisements that appear annually in Stroke and in the “Best Hospitals” issue of U.S. News & World Report. www.heart.org 

An added benefit is combining the Centers for Medicaid and Medicare/The Joint Commission - CMS/TJC Core Measure Stroke module with the GWTG-Stroke module for a comprehensive stroke registry module.  The CMS/TJC Stroke module has approximately 56 fields and records with identical definitions cross-over to GWTG-Stroke.  In addition for qualifying for CMS reimbursement, TJC awards Primary Stroke Center Certification to hospitals meeting their criteria.  The Joint Commission's Primary Stroke Center Certification Program, launched in December 2003, was developed in collaboration with the American Heart Association/American Stroke Association (AHA/ASA).  As of January 1, 2011, there are more than 800 certified primary stroke centers in 49 states.  Certification is available only to stroke programs in Joint Commission-accredited acute care hospitals.  www.jointcommission.org/stroke 


heartbase Reporting Queue (hbQ)

In December 2011, continuing the commitment to product enhancement, heartbase, Inc. released a report processing enhancement tool,  hbQ, which allows reports to be sent to a queue on the hospital server for batch processing.  This will eliminate waiting for a report to run before requesting another.  

With hbQ, report parameters are filled in, e.g. date range, hospital and procedure type and is submitted for processing and user may move onto further report requests.  When reports are finished, they will appear in a processed report queue, based on the heartbase report directory.  . 

hbRepQ Benefits

·         Significant improvement in event (harvest, audits and eports)  production speed

·         Expanded Report Management Capabilitieso    Tracking of report progresso    Management of reports once produced, including ability to look at reports multiple times without the need of re-running the report.o    Queuing of report requestso    Report Distribution

·         Easy to use and improved user Interface

·         Designed in anticipation of 2014 meaningful use criteria for EP and Cath Lab Report Content.

·         Designed in anticipation of creating standard monthly and quarterly report requests.

·         Security improvements, including optional report tracking by user.

Key Concepts

·         Services - All event requests are handled via a service that runs on your server, named CFR__queue.  This service allows event requests to be received 24/7.

·         Separation of Query from Report - The query request function has been separated from the actual report run.  It is not necessary to wait for reports to finish.  As soon as the report parameters are completed, the report is sent to the queue along with a pop-up acknowledgement stating the report has been sent to the queue.  The actual query is executed on the server.  Once the reports are queued, the user is free to log out of heartbase completely.

 


Web-Based Application

In the 2013, heartbase will release its web-based application and will be available via the IPad.  Eliminating the “client/server” application, work station requirements and the need to install software on specific workstations, the user will enter a specific address via a web-browser that connects up to the heartbase server and displays information.  The primary benefit is portability and the assignment of workflow. 


Network Merged Reporting
Collecting clinical data from sites within a network, data is consolidated at the executive/corporate level for benchmark analysis within the network.  Reports provide detail analysis of site performance, comparing  outcome measures by hospital to internally set network performance standards and national standards. 
Acute Drug Reaction (ADR)
Provides users with the ability to track, document, analyze and benchmark the clinical parameters associated with adverse drug reactions and medication errors at the patient level in an effort to reduce incidence of these events.  Linking Pharmacy and Quality Management, new and recurring adverse drug interactions are monitored and drug administering adjustments are noted at the procedure and patient level within the heartbase system.  ADR fully integrates into the heartbase system or may be purchased as a stand-alone module.
Electrophysiology Module (EP)
In addition to collecting patient history and complications and outcome information, the following diagnostic and therapeutic procedures are collected: EPS, Tilt Table, Cardioversion and Non-Invasive ICD checks, Ablation, ICD and Pacemaker insertions.  Detailed tracking includes but is not limited to procedural indications, medications and anesthesia and device data.  The EP Module may be combined with the ICD Registry module or purchased as a standalone module.  The combination provides powerful electrophysiology data fulfilling CMS requirements and linking directly to the ICD Registry for primary population harvests.  The module incorporates information from demographic, hospitalization, clinical presentation, and examines procedure and complications in detail.
Heart Transplant
Module provides users with an overview of patient history, detailed surgical transplantation data and complications/outcomes to assist in successfully building and maintaining a high-level transplant program.
HIPAA Security (Advanced Version)
Security measures include user defined encrypted passwords, role base and relationship based access controls, user ID audit trails and single sign-on from Windows sign-on.  Users are assured that their confidential clinical data is protected from unauthorized access and that their data repository is HIPAA compliant.
Inventory
Users may track and administer equipment in the cardiac lab environment, produce reports that aid in the management of medical equipment inventory at a point in time and from an historical perspective and link inventory to patient data to allow the allocation of equipment associated with each procedure.  In addition to inventory accounting and controls for single or multiple warehouse/hospital locations, module features include but are not limited to generating automatic purchase orders, maintaining supplier and manufacturer information, handling inventory by serial number, size and length, tracking orders – backorder, expected deliveries and reorder points, recording UPC Bar code information and producing audit trails including long-term archival of records.  Module may be purchased as a stand-alone or integrated inventory management system.
Lab Systems
Module integrates into the heartbase system and warehouses all lab values of interest into heartbase as transactions occur.  A heartbase listener program is created to receive all lab transactions.  Lab value history is maintained and heartbase displays lab history by patient.  Lab values may be used to create variables for STS and ACC harvests.  Medications are stored in standards predicated by the ACC and STS.
Non-Invasive Testing
Provides users with advanced database capabilities for Resting/Stress Echo/Adenosine Nuclear Tests, Resting/Stress Echo Tests, Resting EKG Tests, Exercise Stress Tests and MUGA Tests.  General report design options are available plus instant test reports for patients and referring physicians.
Surgical Op-Notes

heartbase Op Notes combine STS Adult Cardiac Surgery data with a site/physician customized narrative to create a new generation of automated operative notes while streamlining the process of physician dictation and data collection for open heart surgeries.  Automatically generated within the heartbase database, the Op Notes include patient information, a detailed description of the open heart surgical procedures and findings, and a precise image of the patient’s coronary tree with grafts.  The interface with the transcription system provides the option of supplementing the report with additional dictation.  OR procedure data may be entered by the attending surgeon or perfusionist and once entered, the report resides in the patient’s permanent chart record.  Graft definitions utilize the STS data points and the heartbase screen variables translate into sentences and paragraphs, once language and context has been customized by the physician.  Op-Notes save approximately 25 minutes of dictation time per physician.  Benefits of Purchasing the heartbase Op Notes System  

Benefits of Purchasing the heartbase Op Notes System  

• Savings of 20-30 minutes of surgeon time per op note

• Validation of data in Op Note to data in database

• Concurrent Data Collection

• STS data completion

• Perfusionist Report Preparation

• Integration into hospital electronic medical record

• Transcription savings

• Physician ability to dictate additional findings

• Electronic Signature• Op Note speed up to referring MD by 1-2 days

• Medical record interaction

• Flash drive patient record

• E-Mail to referring cardiologist

• Optional customization of report for physicians

• Coding Improvements for billing• MD bonus program


Interfaces
heartbase™ further streamlines workflow and data collection while maximizing system-wide interoperability with the addition of a host of vendor neutral interfaces: Admission/ Discharge/ Transfer(ADT), hemodynamic monitoring, imaging, billing, EHR/EMR, inventory, financial, lab and pharmacy systems. The yearly cost savings are significant and the heartbase™ system has proven to be fully self-funding in a majority of its installations due to the elimination of data entry redundancy and a decrease in FTE expenditure and allocation.  heartbase™ has proven expertise in custom protocol design and successful and timely installations.   ·         Hemodynamic Interface: Once a case is completed in the Cath Lab, the data is automatically routed to an interface “service”, which in turns updates the heartabase™ repository with corresponding discrete data elements. There is no manual re-entry from a results log. The user is only responsible for entering in elements that were not captured in the interface file produced by the Cath Lab.  Specializing in custom protocol design, ADT and hemodynamic interfaces yield  approximately 75-100% of the data required to participate in the ACC-Cath/PCI Registry.   ·         ADT Interface:  Automatically collecting admit, discharge and transfer patient information,  heartbase,Inc. does differ from the competition: the heartbase™ ADT captures all transactions/changes from the admitting system, rather than having to request the patient from the CVIS. As the patient is changed on the Admitting side, that change is also reflected on the heartbase side without incurring manual re-entry.
NCDR PVI Registry


heartbase, Inc. received certification from the American College of Cardiology for the Peripheral Vascular Intervention (PVI) Registry on June 16, 2014.

Launched in April 2014, the ACC-NCDR PVI Registry will serve as a national surveillance system to assess the prevalence, demographics, management, and outcomes of patients undergoing carotid artery stenting (CAS), carotid endarterectomy (CEA), and lower extremity peripheral arterial catheter-based interventions (LE).

The registry will expand on the existing ACC-NCDR CARE Registry® to meet the need for additional information about the use and outcomes of interventional procedures for the treatment of peripheral arterial disease (PAD) and assessment to improve care paths utilizing endovascular technologies and treatments.

According to the ACC, participants have the option to submit to CAS/CEA and LE or just CAS/CEA or LE.   The hbCOR™ PVI modules are twofold and include a carotid and/or lower extremity package to meet ACC criteria for submission.

CAS/CAE/LE (“bundle” package)

CAS/CAE or LE (individual subsets)

The module will generate data to support outcomes-based evidence for new and emerging treatment modalities, and provide cost benefit ratio evaluations of newer, more expensive devices and pharmacologic therapies, including off-label device use.





 
  © Copyright 2015 Heartbase, Inc. All rights reserved.
Phone 773-267-7400 | Fax: 773-267-7454 | info@heartbase.net
3723 North Elston - 1 North | Chicago, IL 60618